Onpattro 10 MG/5 ML vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMEG7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,610
Award facts
- Contract value 100% obligated
- $14,609.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $14,609.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Onpattro 10 mg/5 ml vials. This firm fixed-price delivery order, issued on January 28, 2026, with an ultimate completion date of February 19, 2026, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The delivery will be performed at DMS Pharmaceutical Group's Park Ridge facility and represents a typical transactional purchase within the company's broader pharmaceutical supply relationship with the Department of Defense.
This award is issued under DMS Pharmaceutical Group's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) Indefinite Delivery Contract with the Defense Logistics Agency, a $499.99 billion framework established on November 13, 2025, that authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy through which DLA establishes multiple regional prime vendor contractors to ensure reliable pharmaceutical supply chains for military healthcare facilities worldwide, with DMS Pharmaceutical Group positioned as one of several prime vendors under this critical initiative.
Quick answers
Who was awarded contract SPE2DR26FMEG7?
SPE2DR26FMEG7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FMEG7 worth?
The government has obligated $14,610 on SPE2DR26FMEG7.
Is contract SPE2DR26FMEG7 an order under another contract?
Yes. SPE2DR26FMEG7 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEG7 competed?
The extent of competition for SPE2DR26FMEG7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award